GSK
GlaxoSmithKline PLC
47.00$
-0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 44.8 | 74.6 | 110.1 | 89.8 | 33.0 | 39.4 | 22.6 | 24.1 | 27.8 | 24.7 | 22.4 | 21.5 | 16.9 | 15.6 | 49.3 | 17.7 | 19.3 | 19.3 | 30.2 | 9.4 | 82.9 | 45.8 | 21.0 | 20.3 | 12.9 | 16.3 | 4.8 | 15.5 | 27.2 | 17.6 | |
| 10.7 | 17.3 | 25.3 | 19.2 | 7.6 | 5.9 | 4.2 | 5.0 | 5.4 | 5.3 | 5.2 | 4.9 | 3.2 | 3.0 | 2.8 | 3.4 | 3.3 | 4.0 | 3.6 | 3.3 | 2.7 | 2.3 | 2.5 | 2.8 | 3.0 | 2.9 | 2.4 | 2.5 | 2.2 | 3.1 | |
| 73.0 | 74.9 | 74.8 | 51.8 | 17.8 | 16.2 | 13.5 | 14.0 | 19.0 | 15.8 | 12.8 | 11.7 | 9.8 | 8.6 | 9.1 | 11.6 | 14.9 | 15.0 | 16.9 | 8.9 | 15.2 | 20.1 | 20.1 | 6.2 | 3.7 | 3.5 | 6.8 | 4.5 | 5.1 | 6.2 | |
| 10.9 | 17.4 | 25.5 | 19.4 | 7.8 | 6.2 | 4.4 | 5.4 | 5.8 | 5.7 | 5.5 | 5.6 | 3.9 | 3.7 | 3.4 | 4.0 | 4.2 | 4.8 | 4.6 | 3.7 | 3.2 | 2.8 | 3.2 | 3.5 | 3.9 | 3.7 | 3.0 | 3.0 | 2.6 | 3.5 | |
| 24.9 | 42.3 | 62.9 | 51.3 | 19.9 | 18.3 | 14.4 | 15.9 | 17.6 | 96.8 | 14.7 | 13.7 | 10.9 | 10.3 | 17.3 | 11.0 | 12.5 | 14.5 | 20.7 | 7.0 | 20.2 | 13.5 | 13.3 | 13.0 | 11.7 | 14.1 | 10.3 | 9.9 | 12.4 | 11.0 | |
| 199.7 | 689.8 | – | – | 183.6 | 34.9 | 48.5 | 28.5 | 24.1 | 26.3 | 50.9 | 30.7 | 14.9 | 14.5 | 15.6 | 18.9 | 30.4 | 19.0 | 24.3 | 118.2 | 18.2 | 14.9 | 11.5 | 16.1 | 12.0 | 14.2 | 13.9 | 12.2 | 19.6 | 17.3 | |
| 0.5% | 0.1% | 0.0% | -0.1% | 0.5% | 2.9% | 2.1% | 3.5% | 4.1% | 3.8% | 2.0% | 3.3% | 6.7% | 6.9% | 6.4% | 5.3% | 3.3% | 5.3% | 4.1% | 0.8% | 5.5% | 6.7% | 8.7% | 6.2% | 8.4% | 7.0% | 7.2% | 8.2% | 5.1% | 5.8% | |
| Margins | ||||||||||||||||||||||||||||||
| 100.0% | 100.0% | 80.6% | 49.0% | 78.1% | 78.4% | 78.3% | 78.8% | 78.2% | 78.0% | 78.4% | 77.1% | 73.7% | 74.0% | 72.2% | 72.1% | 70.0% | 67.6% | 68.2% | 63.0% | 66.7% | 65.7% | 66.8% | 64.9% | 67.4% | 66.9% | 67.4% | 71.8% | 71.2% | 72.4% | |
| 37.5% | 35.4% | 33.6% | 30.9% | 26.2% | 29.7% | 26.2% | 29.8% | 26.3% | 31.7% | 31.0% | 34.9% | 29.3% | 29.7% | 13.3% | 28.5% | 27.6% | 26.5% | 15.6% | 43.1% | 9.3% | 13.5% | 17.8% | 20.6% | 24.6% | 17.6% | 21.9% | 22.2% | 12.8% | 25.5% | |
| 23.9% | 23.2% | 23.0% | 21.3% | 23.0% | 15.1% | 18.6% | 20.9% | 19.6% | 21.6% | 23.2% | 23.0% | 18.9% | 19.5% | 5.8% | 19.2% | 17.0% | 20.5% | 12.0% | 35.2% | 3.3% | 5.1% | 11.8% | 13.8% | 23.6% | 17.8% | 51.0% | 16.2% | 8.2% | 17.5% | |
| 5.4% | 2.5% | -0.8% | -1.0% | 4.1% | 17.0% | 8.6% | 17.7% | 22.6% | 20.3% | 10.2% | 16.1% | 21.5% | 21.0% | 18.2% | 18.0% | 10.8% | 20.8% | 14.9% | 2.8% | 14.9% | 15.6% | 21.5% | 17.4% | 25.5% | 20.3% | 17.5% | 20.6% | 11.4% | 17.8% | |
| Returns | ||||||||||||||||||||||||||||||
| 163.0% | 100.4% | 67.9% | 57.6% | 54.0% | 41.1% | 59.8% | 58.1% | 68.2% | 64.1% | 57.4% | 54.4% | 58.0% | 55.3% | 18.4% | 65.5% | 77.4% | 77.7% | 55.8% | 94.9% | 18.4% | 43.9% | 95.8% | 30.7% | 28.8% | 21.5% | 141.1% | 29.0% | 18.8% | 35.0% | |
| 24.0% | 21.9% | 19.6% | 17.4% | 19.3% | 14.1% | 17.6% | 18.7% | 17.0% | 17.2% | 21.1% | 16.8% | 11.7% | 12.9% | 3.9% | 12.8% | 10.8% | 12.9% | 6.8% | 15.8% | 1.5% | 2.7% | 6.2% | 4.4% | 5.2% | 4.1% | 24.9% | 6.6% | 4.3% | 9.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| 1,285 | 966 | 1,077 | 2,033 | 3,617 | 4,477 | 5,476 | 7,003 | 7,509 | 6,945 | 8,059 | 14,148 | 17,599 | 18,831 | 17,028 | 15,944 | 23,376 | 22,872 | 23,282 | 10,755 | 13,852 | 13,213 | 22,146 | 25,509 | 19,916 | 19,660 | 17,264 | 13,997 | 12,359 | 13,631 | |
| 0.4 | 0.3 | 0.3 | 0.6 | 0.5 | 0.6 | 0.8 | 1.0 | 1.1 | 5.5 | 0.9 | 1.5 | 2.0 | 1.8 | 3.0 | 1.6 | 2.7 | 2.6 | 4.5 | 0.8 | 3.1 | 2.1 | 3.0 | 2.8 | 2.5 | 3.0 | 2.0 | 1.5 | 1.9 | 1.3 | |
| 14.7% | 21.8% | 28.9% | 30.1% | 35.7% | 34.3% | 29.5% | 32.2% | 24.9% | 26.9% | 36.7% | 31.0% | 20.1% | 23.3% | 21.1% | 19.6% | 14.0% | 16.6% | 12.1% | 16.6% | 8.4% | 6.2% | 6.5% | 14.3% | 18.1% | 19.0% | 17.6% | 22.6% | 23.0% | 26.8% | |
| 1.3 | 0.6 | 0.5 | 0.7 | 0.6 | 0.7 | 1.0 | 1.0 | 1.7 | 1.5 | 1.1 | 1.8 | 2.9 | 2.5 | 2.6 | 2.7 | 4.7 | 4.1 | 5.6 | 1.9 | 3.8 | 4.9 | 6.9 | 2.1 | 1.4 | 1.2 | 2.0 | 1.0 | 1.2 | 1.0 | |
| Per Share | ||||||||||||||||||||||||||||||
| 0.71 | 0.64 | 0.63 | 0.62 | 1.70 | 1.27 | 1.66 | 1.93 | 1.70 | 2.05 | 2.36 | 2.34 | 2.20 | 2.71 | 0.80 | 2.58 | 2.25 | 2.76 | 1.42 | 4.31 | 0.46 | 0.78 | 1.82 | 2.32 | 2.85 | 2.71 | 7.32 | 2.40 | 1.24 | 2.78 | |
| 2.96 | 2.77 | 2.74 | 2.92 | 7.37 | 8.39 | 8.94 | 9.25 | 8.71 | 9.45 | 10.17 | 10.21 | 11.65 | 13.88 | 13.84 | 13.43 | 13.24 | 13.47 | 11.82 | 12.24 | 14.20 | 15.27 | 15.50 | 16.82 | 12.09 | 15.24 | 14.36 | 14.75 | 15.15 | 15.87 | |
| 0.43 | 0.64 | 0.93 | 1.08 | 3.14 | 3.08 | 2.77 | 3.33 | 2.49 | 3.19 | 4.11 | 4.31 | 3.79 | 4.90 | 4.33 | 3.94 | 2.91 | 3.56 | 2.54 | 4.54 | 2.53 | 1.77 | 1.90 | 7.53 | 9.89 | 12.58 | 5.19 | 8.28 | 6.60 | 7.94 | |
| 0.16 | 0.07 | -0.02 | -0.03 | 0.31 | 1.43 | 0.77 | 1.64 | 1.97 | 1.92 | 1.04 | 1.64 | 2.51 | 2.92 | 2.52 | 2.41 | 1.43 | 2.81 | 1.76 | 0.34 | 2.11 | 2.39 | 3.33 | 2.92 | 3.08 | 3.10 | 2.52 | 3.04 | 1.72 | 2.83 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.